Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Isotope Technologies (AIT) is a specialized analytical technology company that provides advanced tools and services for the life sciences, environmental, and clinical sectors. The company is a pioneer in Speciated Isotope Dilution Mass Spectrometry (SIDMS), a method that allows for the precise quantification of chemical species by correcting for sample preparation errors and matrix effects. AIT's portfolio includes enriched stable isotope standards and specialized software designed to enhance the accuracy of mass spectrometry workflows. These technologies are particularly valuable in pharmaceutical research for drug metabolism and pharmacokinetics (DMPK) studies, as well as in environmental testing for trace metal speciation. In early 2023, AIT was acquired by Agilent Technologies, integrating its unique isotope-based solutions into Agilent's broader analytical instrument and reagent business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Isotope Technologies.